Interestingly, targeting negative regulators of the RAS-RAF-MEK-ERK pathway, including DUSP6, leads to cellular toxicity in lung adenocarcinoma [69], further sustaining the possibility that CIC-deregulated tumors have common determinants. Here, DUSP6 is linked to lung adenocarcinoma.